Détail de l'auteur
Documents disponibles écrits par cet auteur (3)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
Ali Abbasi ; Stephan-Jl BAKKER ; Joline-Wj BEULENS ; Eva CORPELEIJN ; Paul-E DE JONG ; Rijk-Ob GANS ; Ron-T GANSEVOORT ; Hans-L HILLEGE ; Bernd KOWALL ; MEISINGER (Christine) : DEU. Helmholtz Zentrum München. German Research Center of Environmental Health. Institute of Epidemiology Ii. Neuherberg. ; Gerjan NAVIS ; Linda-M PEELEN ; Wolfgang RATHMANN ; Ronald-P STOLK ; Department of Epidemiology. University of Groningen. University Medical Center Groningen. RB Groningen. NLD ; Department of Internal Medicine. University of Groningen. University Medical Center Groningen. Groningen. NLD |[BDSP. Notice produite par INIST-CNRS R0x89CGD. Diffusion soumise à autorisation]. Recently, prediction models for type 2 diabetes mellitus (T2DM) in older adults (aged > =55 year) were developed in the KORA S4/F4 study, Augsburg, Germany. We a[...]
Article
Hiddo-J LAMBERS HEERSPINK ; Stephan-Jl BAKKER ; Auke-H BRANTSMA ; Paul-E DE JONG ; Dick DE ZEEUW ; Ron-T GANSEVOORT ; Department of Clinical Pharmacology. University Medical Center Groningen. University of Groningen. Groningen. NLD ; Division of Nephrology. University Medical Center Groningen. University of Groningen. Groningen. NLD ; Prevend Study Group. INC |[BDSP. Notice produite par INIST-CNRS DR0xCEI7. Diffusion soumise à autorisation]. Screening for albuminuria has been advocated because it is associated with cardiovascular morbidity and all-cause mortality. The "gold standard" to assess albumin[...]
Article
Ronald-T GANSEVOORT ; Stephan-Jl BAKKER ; Jacoline BRINKMAN ; Paul-E DE JONG ; Dick DE ZEEUW ; DYER (Alan-R) : USA. Department of Preventive Medicine. Feinberg School of Medicine. Northwestern University. Chicago. IL. ; University Medical Center. Department of Clinical Pharmacology. Groningen. NLD ; University Medical Center. Department of Nephrology. Groningen. NLD |[BDSP. Notice produite par INIST-CNRS AR0xgqco. Diffusion soumise à autorisation]. Albuminuria has recently drawn much attention as a valuable risk marker for cardiovascular and renal disease progression. Albuminuria can be measured and expresse[...]
